The emergence of hantavirus presents a significant challenge for public health. Drawing from personal experience in a biocontainment setting, the urgency for effective action is clear.
Adam Goodcoff argues that hospitals should allow doctors more freedom to address health misinformation on social media platforms.
Preliminary government data indicates a 14% decrease in drug overdose deaths in 2025, with around 70,000 fatalities reported. However, experts express concern over potential policy and drug supply changes.
The Centers for Medicare and Medicaid Services has announced a temporary halt in the enrollment of new hospice and home health providers, effective May 13, 2026.
A recent brief highlights the trends in Medicaid behavioral health coverage, emphasizing the treatment models for serious mental illness and the financial challenges ahead.
Recent findings suggest a potential connection between gene therapy viruses and a tumor in a young boy, raising important questions about the safety of such treatments.
Encoded Therapeutics has alerted gene therapy firms about potential trade-offs associated with a drug designed to enhance safety, which may inadvertently reduce effectiveness.
A boy's tumor has been linked to gene therapy viruses, prompting doctors to emphasize the need for careful consideration of the rare risks versus the significant benefits of such treatments.
While iodine deficiency may seem like a relic of the past, it is resurfacing as a significant health issue, particularly affecting specific groups such as vegans, vegetarians, and pregnant women.
The recent resignation of the FDA head has raised alarms about the agency's stability, with Kyle Diamantas stepping in as acting leader during a critical time.
Marty Makary's resignation from the FDA has raised questions about his understanding of the role. STAT's Matthew Herper offers insights into his controversial tenure.
A recent analysis by Crisis Text Line indicates that male texters are significantly less likely to seek help for suicidal thoughts compared to their female counterparts.
In a significant shift at the Food and Drug Administration, Commissioner Marty Makary is stepping down following a challenging period in leadership, with Diamantas taking over.
As competition in the telehealth sector intensifies, Hims has reported a decline in sales. The company is navigating a challenging landscape, with significant developments in the biotech field.
STAT highlights the ongoing challenges America faces in tackling excessive alcohol consumption, revealing a historical pattern of neglect.
Pharmaceutical companies have ramped up their lobbying efforts, spending over $130 million in 2025, while Bristol-Myers Squibb has announced a new partnership with a Chinese firm.
The gene therapy community expresses concern over the lack of information from Capsida regarding the brain receptor involved in a recent fatal incident.
Researchers are investigating how generative AI could potentially decrease the reliance on animal experiments in drug development, addressing ethical concerns.
The emotional toll of losing a pet extends beyond humans, affecting surviving animals as well. This piece reflects on the grief experienced by both parties.
As incidents of fires linked to improper battery disposal increase, states are debating who should bear the financial responsibility for managing this hazardous waste.